Back

Vascular effects and benefits through Helical stent implantation vs. conventional stenting: Methodology and initial Results of The MIMICS FLOW investigator-initiated randomized controlled trial

28 August 2023 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Lower extremity artery disease: peripheral phenotype of a systemic obliterative genotype needs our attention Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Christos Rammos

University of Duisburg-Essen - West-German Heart and Vascular Centre, Essen (Germany)

8 More presentations in this session

Presentation thumbnail
Association of unilateral low ankle-brachial index and bilateral low ankle-brachial index with incident cardiovascular disease and mortality: The Northern Shanghai Study
Assistant Professor Y. Zhang (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Global epidemiology of lower-extremities artery disease in the 21st century (2000-2021): a systematic review and meta-analysis
Miss C. Adou (Limoges, FR)
Abstract Slides Video
Presentation thumbnail
Usefulness of a novel nutritional index associated with frailty and poor outcomes in patients with lower extremity arterial disease
Assistant Professor Y. Chikata (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Prolonged turbulence and deposition of LDL cholesterol caused atherosclerotic lesion in femoral arteries and spared the iliac arteries. Why? A dynamic angiography and machine learning analysis
Doctor N. Nguyen (Hialeah, US)
Abstract Slides Video
Presentation thumbnail
Acute limb ischemia registry, the forgotten emergency.
Doctor I. Bluro (Buenos Aires, AR)
Abstract Slides Video

Access the full session

Session thumbnail
Lower extremity artery disease: peripheral phenotype of a systemic obliterative genotype needs our attention

The Event

Event poster

ESC Congress 2023

28 August 2023 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Sirolimus vs paclitaxel for femoropopliteal peripheral artery disease - The limus flow randomized trial
thumbnail
Congress Session
Smaller trials, trial updates, and other studies on coronary artery disease and coronary revascularisation
thumbnail
Congress Session
Late-breaking science on acute coronary syndromes

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources